Bio


Dr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.

She is a double board certified in Psychosomatic Medicine and General Psychiatry.

Clinical Focus


  • Psychiatry
  • Consult-Liaison Psychiatry
  • Psycho-Oncology
  • Integrative Medicine

Academic Appointments


Honors & Awards


  • Achievement Award, Loyola University Medical Center Department of Psychiatry
  • Medical Honor Society, Alpha Omega Alpha Medical Honor Society

Boards, Advisory Committees, Professional Organizations


  • Co-Founder and Chief Medical Officer, Savant Care Inc. (2014 - Present)
  • Board Certified in Psychiatry, American Board of Psychiatry and Neurology (2013 - Present)
  • Board Certified in Psychosomatic Medicine, American Board of Psychiatry and Neurology (2015 - Present)

Professional Education


  • Board Certification: American Board of Psychiatry and Neurology, Psychiatry (2013)
  • Board Certification: American Board of Psychiatry and Neurology, Psychosomatic Medicine (2015)
  • Medical Education: Government Med College-Punjab (2008) India
  • Fellowship: Stanford Univ Medical Center (2014) CA
  • Residency: Loyola Univ Of Chicago Stritch (2013) IL
  • Internship: Rajendra Hospital And Med Coll (2008) India
  • MD, Stanford Hospitals and Clinics, Psychosomatic Medicine (Fellowship) (2014)
  • MD, Loyola University Medical Center, Adult Psychiatry (Residency) (2013)

All Publications


  • Response to Letter to the Editor re: Correction About the Nursing Delirium Screening Scale (Nu-DESC) in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium" JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY Maldonado, J. R., Sher, Y. I., Benitez-Lopez, M., Savant, V., Garcia, R., Ament, A., De Guzman, E. 2021; 62 (1): 161-163
  • A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium PSYCHOSOMATICS Maldonado, J. R., Sher, Y. I., Benitez-Lopez, M., Savant, V., Garcia, R., Ament, A., De Guzman, E. 2020; 61 (2): 116–26
  • Does escitalopram reduce neurotoxicity in major depression? Journal of Psychiatric Research Halaris, A. 2015; 66-67 (July-August 2015)